1. Monash Health
  2. Monash Health research
  3. Articles
Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/36970
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGrigoriadis G.en
dc.contributor.authorFedele P.L.en
dc.contributor.authorChee A.en
dc.contributor.authorLow M.S.en
dc.contributor.authorVilcassim S.en
dc.contributor.authorGregory G.P.en
dc.contributor.authorGilbertson M.en
dc.contributor.authorRatnasingam S.en
dc.date.accessioned2021-05-14T12:33:32Zen
dc.date.available2021-05-14T12:33:32Zen
dc.date.copyright2018en
dc.date.created20180831en
dc.date.issued2018-08-31en
dc.identifier.citationBritish Journal of Haematology. 182 (5) (pp 739-741), 2018. Date of Publication: September 2018.en
dc.identifier.issn0007-1048en
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/36970en
dc.languageenen
dc.publisherBlackwell Publishing Ltden
dc.relation.ispartofBritish Journal of Haematologyen
dc.titleFailure to achieve early disease response is associated with inferior survival in patients with newly diagnosed multiple myeloma.en
dc.typeLetteren
dc.type.studyortrialOpinion, perspective or news-
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1111/bjh.14871en
dc.publisher.placeUnited Kingdomen
dc.identifier.orcidChee, Adrian; ORCID: http://orcid.org/0000-0001-6602-6447en
dc.identifier.pubmedid28857117 [http://www.ncbi.nlm.nih.gov/pubmed/?term=28857117]en
dc.identifier.source618120870en
dc.identifier.institution(Chee, Low, Vilcassim, Gregory, Gilbertson, Ratnasingam, Grigoriadis, Fedele) Monash Haematology, Monash Health, Clayton, Australia (Low, Fedele) Walter and Eliza Hall Institute of Medical Research, Parkville, Australia (Vilcassim, Gregory, Grigoriadis) School of Clinical Sciences at Monash Health, Monash University, Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, VIC, Australiaen
dc.description.publicationstatusEmbaseen
dc.rights.statementCopyright 2019 Elsevier B.V., All rights reserved.en
dc.subect.keywordsbortezomib multiple myeloma proteasome inhibitorsen
dc.identifier.authoremailFedele P.L.; pasquale.fedele@monashhealth.orgen
dc.description.grantOrganization: *Janssen Pharmaceuticals* Organization No: 100008897 Country: United States Organization: *Leukaemia Foundation* Organization No: 501100000926 Country: Australia Organization: (MU) *Monash University* Organization No: 501100001779 Country: Australia Organization: (NHMRC) *National Health and Medical Research Council* Organization No: 501100000925 Country: Australiaen
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.openairetypeLetter-
crisitem.author.deptHaematology-
crisitem.author.deptHaematology-
crisitem.author.deptHaematology-
Appears in Collections:Articles
Show simple item record

Page view(s)

16
checked on Sep 11, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.